GlassScriptPhysician profile
Ashish Ashwin Gajjar
NPI 1538470562
$11,120.42
in general payments reported to CMS, 2019-2025
5 companies · $830 in 2025
The $830 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,660 · 2022: $3,607 · 2023: $2,887 · 2024: $2,137 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,588 · Travel and Lodging: $2,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,587.69 |
| Travel and Lodging | $2,266.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,589.68 | 2021-2025 | Target, Axs Infinity Ls, Neuroform Atlas |
| Penumbra, INC. | $3,501.87 | 2022-2024 | Penumbra System, Red 72 |
| Microvention, INC. | $1,588.62 | 2022-2023 | Sofia 6f-131cm Str, Web Aneurysm Embolization System, Stent |
| Imperative Care, INC | $805.66 | 2024-2025 | Zoom Reperfusion Catheter, Zoom 88-T Large Distal Platform |
| Route 92 Medical, INC. | $634.59 | 2024-2025 | 8f Base Camp Sheath System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Gajjar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.